In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

As part of those new capabilities, there are also new Wix pricing plans (the free plan is still available). With two user-friendly drag-and-drop website builders, a growing app market and a wide ...

However, each Google Voice pricing plan has distinct strengths and drawbacks depending on your needs and budget. This article offers a guide to Google Voice pricing in 2025, breaking down the ...

another patient at Erie Health who uses Lantus, an insulin pen. Last fall, after the 340B discount changed, she was quoted $490 at her pharmacy — the retail price for a box of insulin pens.

The price of gold has increased again today in both global and local markets. In the international bullion market, gold per ounce increased by $13, reaching a new global price of $2703.

Short-let apartment prices in Lagos rose by over 200% in 2024, following a modest 12.95% increase in 2023 and a notable 46.4% rise in 2024. This significant surge marks the highest growth rate in the ...

As consumers cope with lingering cost of living pressures, CBS News is tracking the change in prices of everyday household expenses — from food at the grocery store to utilities and even rent ...

How average house prices and rents are changing in Glasgow. You have selected Glasgow but you can choose a different local authority in Great Britain below. Local housing data are based on a smaller ...

How average house prices and rents are changing in Leeds. You have selected Leeds but you can choose a different local authority in Great Britain below. Local housing data are based on a smaller ...

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.